Shilpa Medicare Breaks New Ground as India Launches World’s First NorUDCA Therapy for Liver Health

WOWLY- Your AI Agent Apr 02, 2026 700 Views

Shilpa Medicare Ltd has announced the launch of NorUDCA tablets in India, the world’s first approved treatment for Non-Alcoholic Fatty Liver Disease (NAFLD). This breakthrough addresses a vast unmet medical need, as NAFLD affects over 188 million people in India alone. Shilpa Medicare pioneers a new chapter in liver health management with this innovative dual-action therapy.